FDA Approves Ipsen’s Onivyde® as Promising First-Line Treatment for Metastatic Pancreatic Adenocarcinoma
Ipsen (Euronext: IPN; ADR: IPSEY) has announced the approval by the U.S. Food and Drug Administration (FDA) of the supplemental new drug application for Onivyde® (irinotecan liposome injection) in combination…
Ana Petry Utilizes Professional Expertise to Navigate Life After Personal Tragedy
For Ana, this work held profound significance long before she realized she would eventually benefit from it herself. In October 2022, tragedy struck when her older brother, a successful entrepreneur…
U.S. FDA Conducts Inspection of Lupin’s Dabhasa Facility, Finds No Observations
Lupin Limited, a leading global pharmaceutical company, announced today that the United States Food and Drug Administration (U.S. FDA) has successfully completed a Good Manufacturing Practice (GMP) Inspection of its…
Strengthening Global Health and Well-Being: Collaborative Efforts between WHO and the Netherlands
The Hague, April 10, 2024—In a significant milestone for their enduring partnership, the World Health Organization (WHO) and the Netherlands convened to discuss shared priorities and the alignment of strategic…
Nigeria Leads Globally with Introduction of Revolutionary 5-in-1 Meningitis Vaccine
In a groundbreaking development, Nigeria has emerged as the global pioneer in introducing a new vaccine, known as Men5CV, endorsed by the World Health Organization (WHO). This innovative vaccine provides…
Jazz Pharmaceuticals to Present Comprehensive Neuroscience Portfolio at Annual American Academy of Neurology Meeting
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has revealed that its expansive neuroscience portfolio and pipeline will be prominently featured at the 76th Annual American Academy of Neurology Meeting (AAN), taking place…
Zatolmilast Receives Orphan Medicinal Product Designation from the European Commission: Promising First-in-Class Therapy for Fragile X Syndrome
Shionogi B.V., the European arm of Shionogi & Co., Ltd., has revealed that the European Commission has granted Orphan Medicinal Product designation to zatolmilast (BPN14770), an investigational treatment for Fragile…
Baxter Broadens Pharmaceutical Portfolio with Fresh Injectable Offerings in the U.S.
Baxter International Inc. (NYSE:BAX), renowned globally for its excellence in injectables, anesthesia, and drug compounding, has unveiled a significant expansion of its Pharmaceuticals portfolio with the introduction of five new…
Update: Intangible Asset Impairment, Contingent Consideration Fair Value, FY2023 Financial Forecast Revision
Today, Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced an anticipated booking of approximately ¥70.0 billion in the fourth quarter of fiscal year 2023. This booking…
Walgreens Pharmacist Honored as Advocate for Minority Health
As the daughter of immigrants, Gabriela Ziccarelli, PharmD, BCACP, is deeply committed to reducing health disparities, particularly among minority communities. With nearly two decades at Walgreens, she has dedicated much…
Commencement of Novartis’ Tender Offer for MorphoSys AG
Novartis has officially released the offer document for its subsidiary, Novartis BidCo AG’s, voluntary public takeover bid for all outstanding shares of MorphoSys AG, inclusive of MorphoSys American Depositary Shares…
FDA Grants Roche Breakthrough Device Designation for Blood Test Advancing Early Alzheimer’s Disease Detection
Roche (SIX: RO, ROG; OTCQX: RHHBY) disclosed today that its Elecsys pTau217 assay has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). Developed in collaboration…